News
A Sizeable Increase In Healthcare Deals Anticipated In 2023
Pharma companies with plenty of cash were on one side of a $200 billion patent cliff. On the other hand, there were a lot...
IT & Data Management
Addressing Diseases Through Technology – A New Revolution
To grasp the intricate pathology of many diseases today, scientists and researchers have achieved amazing advances in basic science. The ability of the human...
Clinical Trials
Update On The Clinical Trials Regulation Implementation
The Clinical Trial Information System went live on January 31, 2022, which began the one-year transition period for all clinical trial sponsors. Clinical trial...
IT & Data Management
5 Challenges That Will Affect Developing Biotech In 2023
Drugmakers' initial stock offerings, which had been a dependable tradition for years, mostly stopped in 2022. Fewer than two dozen biotech businesses priced initial...
Drug Research
5 FDA Announcements To Pay Attention To In The 2023 Q1
The biotechnology sector had a decline in 2022 that went beyond just falling stock prices. Additionally, only 37 new drugs were approved by the...
Drug Research
Watch Out For These Potential Best-Seller Drugs In 2023
In the 70 pharmaceuticals featured in Clarivate Plc's Drugs to WatchTM 2023 study, comprising potential blockbuster drugs, the bulk were found to be personalised...
Press Releases
Abzena hires Matthew Stober to lead the company through the next phase of global growth
Abzena, the leading end-to-end integrated CDMO for Antibody Drug Conjugates (ADCs) and complex biologic molecules, announced that Matthew Stober has joined as their new...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read